Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Estrella Immunopharma, Inc. entered into Registration Rights Agreement with White Lion Capital, LLC (effective 2023-04-20).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- White Lion Capital, LLC
- Effective
- 2023-04-20
Exact text from the filing
Concurrently with the execution of the Common Stock Purchase Agreement, the Company entered into the RRA with the White Lion in which the Company has agreed to register with the SEC the shares of Common Stock purchased by White Lion under the Common Stock Purchase Agreement and the shares of Common Stock to be issued upon the conversion of Estrella Series A Preferred Stock for resale within 30 days of the consummation of the Business Combination.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Estrella Immunopharma, Inc. entered into Common Stock Purchase Agreement with White Lion Capital, LLC valued at up to $50,000,000 (effective 2023-04-20).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- White Lion Capital, LLC
- Value
- up to $50,000,000
- Effective
- 2023-04-20
Exact text from the filing
On April 20, 2023, TradeUP Acquisition Corp. (the “Company”) entered into a common stock purchase agreement (the “Common Stock Purchase Agreement”) and a related registration rights agreement (the “RRA”) with White Lion Capital, LLC, a Nevada limited liability company (“White Lion”).
View on SEC.gov